CHERYL CONWAY: Open Payments
NPI 1366847485 · OWENTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 53 payments from 15 companies in 2025. Trend: 2023 $849 · 2024 $1,589 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $264 |
| ABBVIE INC. | 11 | $143 |
| GlaxoSmithKline, LLC. | 9 | $139 |
| Lilly USA, LLC | 8 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Novo Nordisk Inc | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Verona Pharma, Inc. | 1 | $24 |
Products named: BREZTRI, VRAYLAR, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, XIFAXAN, CAPLYTA, LAGEVRIO.
Industry payments across KY — which companies pay providers there.
